Are you passionate about advancing research in virology and immunology? The FDA Fellowship in Understanding Pathogenesis and Markers of Flavivirus Infections presents a unique opportunity for individuals with a background in life sciences to contribute to cutting-edge projects in the Office of Blood Research and Review (OBRR) at the Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA) in Silver Spring, Maryland.
Table of Contents
Introduction and Background
The FDA Fellowship focuses on transfusion-transmissible arboviruses, particularly flaviviruses like Dengue virus, yellow fever virus, West Nile virus, and Zika virus. The aim is to deepen our understanding of infection biology, pathogenesis, and to identify biomarkers for accurate diagnostic differentiation among these viruses.
Table of Briefs
Category | Details |
---|---|
Recruitment Started | January 19, 2024 |
Application Deadline | March 31, 2024, 3:00 PM Eastern Time Zone |
Anticipated Start Date | January 2024 (Flexible) |
Duration | One year, renewable based on funds |
Stipend | Monthly stipend based on education and experience |
Location | Silver Spring, Maryland |
Eligibility | Bachelor’s, Master’s, or Doctoral Degree received within the last 60 months or currently pursuing in Life Sciences |
Eligibility Criteria
To be eligible for this exciting opportunity, candidates must have received or be currently pursuing a BS, MS, or Ph.D. in life sciences. The degree must be received before the start of the appointment and within 5 years of the appointment start date.
Benefits
The fellowship offers a comprehensive research experience in the development of specific and sensitive diagnostic devices to discriminate among flaviviruses. Participants will engage in projects related to virology, immunology, and regulatory science applications associated with emerging infectious diseases.
Application Process
Applications will be reviewed on a rolling basis, and the opportunity will remain open until filled. To apply, visit the FDA Fellowship Application Portal and submit your application before the deadline on March 31, 2024, 3:00 PM Eastern Time Zone.
Important Dates
- Recruitment Started: January 19, 2024
- Application Deadline: March 31, 2024, 3:00 PM Eastern Time Zone
- Anticipated Start Date: January 2024 (Flexible)
Conclusion
This FDA Fellowship provides a remarkable chance for individuals passionate about advancing research in virology and immunology. Don’t miss out on this opportunity to contribute to cutting-edge projects and gain valuable experience in a prestigious institution.